[1] TORRE LA,BRAY F,SIEGEL RL,et al. Global cancer statistics,2012[J]. CA Cancer J Clin,2015,65(2):87-108.
|
[2] Chinese Expert Consensus Statement Chinese Society of Liver Cancer(CSLC), Chinese Society of Clinical Oncology(CSCO),Liver Cancer Group,Chinese Society of Hepatology.Consensus on standardized diagnosis and treatment of primary liver cancer[J]. J Clin Hepatol,2009,25(2):83-92.(in Chinese)中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].临床肝胆病杂志,2009,25(2):83-92.
|
[3] BETTINGER D,GKIKA E,SCHULTHEISS M,et al. Comparison of local tumor control in patients with HCC treated with SBRT or TACE:A propensity score analysis[J]. BMC Cancer,2018,18(1):807.
|
[4] WANG H,PAN YG,XIA JT,et al. Clinical effect of transcatheter arterial chemoembolization in treatment of primary liver cancer:Application and research advances[J]. J Clin Hepatol,2018,34(2):414-418.(in Chinese)王辉,潘裕国,夏金堂,等.经肝动脉化疗栓塞术在原发性肝癌治疗中的应用[J].临床肝胆病杂志,2018,34(2):414-418.
|
[5] CHIANG CL,CHAN MKH,YEUNG CSY,et al. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma[J]. Strahlenther Onkol,2019,195(3):254-264.
|
[6] WANG HY. Clinical effect of Embosphere microsphere in transarterial chemoembolization for liver cancer[D]. Qingdao:Qingdao University,2017.(in Chinese)王洪雨.Embosphere微球在肝癌TACE治疗中的临床疗效分析[D].青岛:青岛大学,2017.
|
[7] WU BL,ZHOU J,LING GH,et al. Efficacy and safety analysis of 8Spheres microspheres combined with lipiodol TACE in the treatment of hepatocellular carcinoma[J]. Med J Wuhan Univ,2018,39(2):248-252.(in Chinese)吴宝林,周军,凌公豪,等.8Spheres微球联合碘油TACE治疗原发性肝癌的疗效及安全性[J].武汉大学学报:医学版,2018,39(2):248-252.
|
[8] National Health and Family Planning Commission of the People's Republic of China. Diagnosis,management,and treatment of hepatocellular carcinoma(V2017)[J]. J Clin Hepatol,2017,33(8):1419-1431.(in Chinese)中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范(2017年版)[J].临床肝胆病杂志,2017,33(8):1419-1431.
|
[9] Chinese College of Interventionalists,Chinese Med. Chinese Clinical Practice Guidelines for transarterial chemoembolization of hepatocellular carcinoma[J]. Chin J Radiol,2019,54(3):246-255.(in Chinese)中国医师协会介入医师分会.中国肝细胞癌经动脉化疗栓塞治疗(TACE)临床实践指南[J].中华放射学杂志,2019,54(3):246-255.
|
[10] SEYAL AR,GONZALEZ-GUINDALINI FD,ARSLANOGLU A,et al. Reproducibility of m RECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma[J]. Hepatology,2015,62(4):1111-1121.
|
[11] CHEN LC,CHIOU WY,LIN HY,et al. Comparing stereotactic ablative radiotherapy(SABR)versus re-trans-catheter arterial chemoembolization(re-TACE)for hepatocellular carcinoma patients who had incomplete response after initial TACE(TASABR):A randomized controlled trial[J]. BMC Cancer,2019,19(1):275.
|
[12] LIU LB,WANG JF,CHENG GH,et al. Explanation of diagnostic criteria for radiation-induced liver diseases[J]. Int J Radiat Med Nuclear Med,2012,36(4):252-255.(in Chinese)刘丽波,王剑峰,程光惠,等.《放射性肝病诊断标准》解读[J].国际放射医学核医学杂志,2012,36(4):252-255.
|
[13] LI SY,WU S,CHEN TS,et al. Effect of portal venous perfusion cinobufacini injection combined with TACE in patients with intermediate hepatocellular carcinoma[J]. Clin J Med Offic,2017,45(9):884-886.(in Chinese)李淑英,吴申,陈挺松,等.经导管肝动脉栓塞化疗联合华蟾素门静脉灌注治疗中期原发性肝癌疗效研究[J].临床军医杂志,2017,45(9):884-846.
|
[14] KOTHARY N,WEINTRAUB JL,SUSMAN J,et al. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk[J]. J Vasc Interv Radiol,2007,18(12):1517-1526; quiz 1527.
|
[15] ZHU LL,CAI CF,MENG Y. Therapeutic efficiency of transcatheter arterial chemoembolization combined with intensity modulated radiation therapy against un-resectable primary hepatocellular carcinoma[J]. Int J Med Radiol,2019,42(2):149-153.(in Chinese)朱六玲,蔡陈枫,孟岩.TACE联合调强放疗对不可切除原发性肝癌的疗效研究[J].国际医学放射学杂志,2019,42(2):149-153.
|
[16] MA M,NIU TT,SHAO L,et al. Hepatic transcatheter arterial chemoembolization combined with stereotactic radia-tion therapy of primary liver cancer[J]. Trauma and Crit Medicine,2017,5(1):32-35.(in Chinese)马明,牛婷婷,邵亮,等.肝动脉化疗栓塞术联合立体定向放疗治疗较大原发性肝癌临床研究[J].创伤与急危重病医学,2017,5(1):32-35.
|
[17] LENG ZQ,LIANG ZY,SHI S. Clinical effect of interventional treatment,radiotherapy,and multimodality therapy for liver cancer[J]. Chin J Radiat Oncol,2000,9(2):99.(in Chinese)冷祝强,梁赵玉,石珊.肝癌介入治疗放射治疗及综合治疗的疗效分析[J].中华放射肿瘤学杂志,2000,9(2):99.
|
[18] SEONG J,PARK HC,HAN KH,et al. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma:A retrospective study of 158 patients[J]. Int J Radiat Oncol Biol Phys,2003,55(2):329-336.
|
[19] ZHANG YW,ZHANG Y,LING ZH,et al. Clinical effect of threedimensional conformal radiotherapy combined with transarterial chemoembolization versus transarterial chemoembolization alone in treatment of liver cancer:A meta-analysis[J]. J South Med Univ,2009,29(12):2514-2516.(in Chinese)张耀伟,张勇,凌志海,等.三维适形放疗联合TACE与单纯TACE治疗肝癌疗效的meta分析[J].南方医科大学学报,2009,29(12):2514-2516.
|
[20] LUO JJ,YAN ZP,WANG JH,et al. HCC embolized by microspheres and iodized oil compared with by iodized oil alone[J]. Chin Comput Med Imag,2008,14(2):154-159.(in Chinese)罗剑钧,颜志平,王建华,等.微球+碘化油联合栓塞与碘化油单独栓塞治疗肝癌的比较研究[J].中国医学计算机成像杂志,2008,14(2):154-159.
|
[21] ZHANG JX,LI FZ,CHAI J,et al. Clinical and controlled trial of transcatheter arterial chemoembolization with polyvinyl alcohol particle in patients with advanced hepatocellular carcinoma[J]. J Hepatopancreatobiliary Surg,2014,26(3):195-197,203.(in Chinese)张军喜,李发中,柴健,等.微球加碘化油栓塞治疗肝癌疗效的临床对照研究[J].肝胆胰外科杂志,2014,26(3):195-197,203.
|
[22] XU YZ,DING YM,YANG Y. Combining chemoembolization using microspheres with iodized oil in the treatment of hepatocellular carcinoma:A Meta-analysis of randomized controlled trials[J]. Chin J Hepatobiliary Surg,2014,20(1):24-28.(in Chinese)徐彦哲,丁佑铭,杨阳.微球联合碘化油栓塞化疗治疗肝细胞癌的Meta分析[J].中华肝胆外科杂志,2014,20(1):24-28.
|
[23] CAO G,WEN F. Comparison of microspheres embolization with lipiodol embolization[J]. Chin J Interv Imaging Ther,2016,13(8):518-519.(in Chinese)曹广,温峰.微球栓塞与碘油栓塞的比较[J].中国介入影像与治疗学,2016,13(8):518-519.
|
[1] | Teng ZHANG, Quan WANG, Wengang LI, Xuezhang DUAN. Efficacy of stereotactic body radiotherapy combined with sintilimab and bevacizumab in treatment of unresectable hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2025, 41(1): 69-74. doi: 10.12449/JCH250111 |
[2] | Gang REN, Yingjie WANG. Advances in radiotherapy for pancreatic cancer from 2019 to 2020[J]. Journal of Clinical Hepatology, 2021, 37(3): 733-736. doi: 10.3969/j.issn.1001-5256.2021.03.048 |
[3] | Chinese Association for Therapeutic Radiation Oncologists, Chinese Society for Therapeutic Radiology and Oncology, Chinese Medical Association, Committee of Radiation Oncology, Chinese Anti-Cancer Association. Chinese radiotherapy guidelines for primary hepatocellular carcinoma (2020 edition)[J]. Journal of Clinical Hepatology, 2021, 37(5): 1029-1033. doi: 10.3760/cma.j.cn371439-20201208-00001 |
[4] | Precise Radiotherapy Study Group, Chinese Society of Liver Cancer, Chinese Medical Doctor Association, Liver Cancer Study Group, Committee of Radiation Oncology, Chinese Research Hospital Association, Committee of Tumor Radiobiology and Multimodal Imaging and Therapy, Chinese Research Hospital Association, Liver Cancer Study Group, Precise Radiotherapy Branch, Chinese Society of Biomedical Engineering. Consensus on radiation therapy for primary liver cancer (2020)[J]. Journal of Clinical Hepatology, 2021, 37(2): 296-301. doi: 10.3969/j.issn.1001-5256.2021.02.010 |
[5] | Ye ShengLong. Downstaging and conversion treatment of intermediate and advanced liver cancer should be taken seriously[J]. Journal of Clinical Hepatology, 2020, 36(2): 249-251. doi: 10.3969/j.issn.1001-5256.2020.02.001 |
[6] | Yuan ShengXian, Zhou WeiPing. Conversion therapy for hepatocellular carcinoma: Strategies and methods[J]. Journal of Clinical Hepatology, 2020, 36(2): 252-257. doi: 10.3969/j.issn.1001-5256.2020.02.002 |
[7] | Liu YueChen, Gu MengYu, Cheng Yu, Yang GuiYuan. An excerpt of radiation therapy for pancreatic cancer: Executive summary of an ASTRO clinical practice guideline (2019)[J]. Journal of Clinical Hepatology, 2020, 36(1): 50-52. doi: 10.3969/j.issn.1001-5256.2020.01.010 |
[8] | Li ShanShan, Chen Yu. Severe radiation-induced gastritis after radiotherapy for hepatocellular carcinoma: A case report[J]. Journal of Clinical Hepatology, 2019, 35(9): 2048-2049. doi: 10.3969/j.issn.1001-5256.2019.09.033 |
[9] | Wang Hui, Pan YuGuo, Xia JinTang, Zhou MiMi, Cai Chun. Clinical effect of transcatheter arterial chemoembolization in treatment of primary liver cancer: application and research advances[J]. Journal of Clinical Hepatology, 2018, 34(2): 414-418. doi: 10.3969/j.issn.1001-5256.2018.02.044 |
[10] | Wu Jian, Yin Fang, Luo GuanHong, Zheng YangYang, Li Hong, Zhu ShaoHua, Zhang Jing, Zhou XinMin. Clinical effect and safety of transarterial chemoembolization combined with apatinib in treatment of advanced primary liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(4): 775-778. doi: 10.3969/j.issn.1001-5256.2018.04.016 |
[11] | Li TianTian, Sun Jing, Wang Quan, Ding JunQiang, Wang Jia, Xue Hui, Zhang Tao, Duan XueZhang. Clinical effect of stereotactic body radiotherapy in treatment of patients with small hepatocellular carcinoma and related prognostic factors[J]. Journal of Clinical Hepatology, 2018, 34(8): 1702-1706. doi: 10.3969/j.issn.1001-5256.2018.08.022 |
[12] | Wu YuNan, Zhang Dong, Sun KeWei. Clinical effect of Bielong Ruangan decoction combined with transcatheter arterial chemoembolization in treatment of hepatitis B virus-related primary liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(11): 2152-2157. doi: 10.3969/j.issn.1001-5256.2017.11.020 |
[13] | Hu CaiXia, Zheng JiaSheng, Cui ShiChang, Qian ZhiLing. Efficacy of nutritional intervention in patients with primary hepatocellular carcinoma treated by transcatheter arterial chemoembolization[J]. Journal of Clinical Hepatology, 2015, 31(4): 569-572. doi: 10.3969/j.issn.1001-5256.2015.04.022 |
[14] | Liu Qi, Wu ZhenMing, Qi XiuHeng, Guo Qian. Survival analysis of intrahepatic arterial infusion of Endostar combined with transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(2): 225-227. doi: 10.3969/j.issn.1001-5256.2015.02.019 |
[15] | Fang ZiYan, Huang Long, Li Gong. Research progress in radiotherapy for liver tumors reported in 2013 ASTRO Annual Meeting[J]. Journal of Clinical Hepatology, 2014, 30(4): 383-385. doi: 10.3969/j.issn.1001-5256.2014.04.025 |
[16] | Zhou ZhenDong, Zhang LeMing, Wang TingTing, Sun XiaoKe, Chen LiangLiang, Liu Kui. Meta-analysis of transarterial chemoembolization combined with microwave coagulation therapy in treatment of advanced liver cancer[J]. Journal of Clinical Hepatology, 2013, 29(8): 591-595. doi: 10.3969/j.issn.1001-5256.2013.08.010 |
[17] | Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001 |
[18] | Zhan GuoQing, Tan HuaBing, Zhu Lin, Li RuGui, Zhang WeiWei, Hu Bo, Du WeiXing. Antiviral effects of transcatheter hepatic arterial chemoembolization on middle and advanced stage hepatitis B virus-related liver cancer[J]. Journal of Clinical Hepatology, 2010, 26(4): 423-424+431. |
[19] | Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365. |
[20] | Guo ZhanWen, Li Yu, Yan Ying, Tian QiHe, Xu Rui. Clinical study of 3-dimensional conformal radiotherapy on primary liver cancer.[J]. Journal of Clinical Hepatology, 2002, 18(3): 164-165. |